FDA approves first drug for neurotrophic keratitis
The FDA has approved the first treatment for neurotrophic keratitis, which completely healed the rare disease in 70 percent of cases.
List view / Grid view
The FDA has approved the first treatment for neurotrophic keratitis, which completely healed the rare disease in 70 percent of cases.
"The key message of this paper is that to do the best by all our children and to help them survive, all countries should introduce rotavirus vaccination.”
The researchers found that doses were often missed, with some treatments being scheduled twice a year instead of monthly...
A minimally invasive hydrogel technology was administered, and has previously shown to decrease treatment side effects...
“We will work with health care professionals and patients to develop a form of rehabilitation that will be acceptable to all those involved."
Transplantation followed by antiviral therapy cured hepatitis C in 100 percent of patients receiving kidneys from infected donors...
A phase III clinical trial looks to use a patients own stem cells to treat the debilitating disease...
Senescent, or zombie cells, are being targeted with the development of a new nanocarrier drug delivery system.
“Patients will now have an approved therapy that has been shown to decrease the need for blood pressure medication and reduce tumour size in some patients.”
The crystal structure was found to have a half-life of 24 hours and could last in the bloodstream for more than 96 hours...
Researchers are now looking to identify if BACE1 is involved in adult hippocampal neurogenesis, and responsible for the brains ability to repair itself...
Inhibiting protein kinase C-alpha was shown to be a pivotal step towards restoring the damage done by nephritis...
Tiny drug-filled nanocarriers, termed ‘nano-submarines’, are being developed to boost the targeted treatment of headaches and tumours, without damaging healthy tissue...
A drug currently in trials for Parkinson's disease has shown promise in treating heart failure, without the risk of dangerous side effects...
Nanofiber-based wound dressings loaded with vitamin D spur the production of an antimicrobial peptide, a key step forward in the battle against surgical site infections...